
Cost per beneficiary of select drugs in Canada's public drug plans 2019/2020
As of fiscal year 2018/2019, prescription drug Janumet (with the ingredients sitagliptin and metformin) cost, on average, 1,004 Canadian dollars per beneficiary. Janumet is a widely used medicine to treat type 2 diabetes.